Zonisamide CAS number 68291-97-4,active pharmaceutical ingredients (API), trade offers, catalog of manufacturers,technology,buyers & suppliers,exporters & importers, raw materials,pharmaceutical manufacturers,biotech, pharma company,bulk pharmaceutical drugs,

Sitemap | Contact Us

Welcome To Taj Pharmaceuticals Ltd API

© 2004 - 2009 Taj Pharmaceuticals Limited . All rights reserved

developing medical

India

Latin America/ Caribbean

Africa & Middle East

Asia

Russia

Europe

	PRODUCT LIST
	Home
	API
	Pharmaceuticals API List >>
	Chemicals
	Manufacturing
	Product Development
	Product Search
	Agro Chemicals
	Custom Pharma Services
	Contact Us

medical

Zonisamide CAS number 68291-97-4

Zonisamide

CAS number 68291-97-4

Formula Structure :

Systematic (IUPAC) name
1,2-benzisoxazole-3-methanesulfonamide

Identifiers
CAS number 68291-97-4
ATC code N03AX15
PubChem 5734
DrugBank APRD00004

Chemical data
Formula C8H8N2O3S
Mol. mass 212.227 g/mol
Physical data
Melt. point 162 °C (324 °F)

Pharmacokinetic data
Bioavailability
Protein binding 40%
Metabolism Hepatic
Half life 105 hours in red blood cells, 63 hours in plasma
Excretion Renal
Therapeutic considerations
Prescription only
Routes Oral

Zonisamideis an antiseizure drug chemically classified as a sulfonamide and unrelated to other antiseizure agents. The active ingredient is zonisamide, 1,2- benzisoxazole-3-methanesulfonamide.

The empirical formula is C8H8N2O3S with a molecular weight of 212.23. Zonisamide is a white powder, pKa = 10.2, and is moderately soluble in water (0.80 mg/mL) and 0.1 N HCl (0.50 mg/mL).

Information Associated with Product:

DOSAGE

SIDE EFFECTS

PRECAUTIONS

INTERACTION

CONSUMER INFORMATION

PDF DOWNLOAD

WORD DOCUMENT


Product Enquiry	Product Quotation	Sample Request	Place Your Order

Taj pharmaceuticals API Logo

More Api at Taj Pharmaceuticals Ltd.

Quetiapine Fumarate

Quinine Sulfate

Rabeprazole Sodium

Ramipril

Ranitidine Hydrochloride

Risperidone

Rivastigmine Tartrate

Rizatriptan

Rosiglitazone Maleate

Voriconazole

Primidone

	Investor Relations Feedback Contact Worldwide Sitemap

© 2004 - 2009 Taj Pharmaceuticals Limited . All rights reserved
Note:-We are committed to helping you find the right answers to your questions and concerns. However, this web site is not intended to give investment advice, promote the use of Taj Pharmaceuticals Ltd products or provide information on which to base medical treatment. If you have questions regarding any Taj Pharmaceuticals Ltd product or are experiencing a medical emergency, please consult your health care provider.
Additionally, contact information on this web site cannot be used to report adverse drug events. If you are a physician, please follow the procedures required by your country's regulations. Please choose one of the given options to contact us and we will respond to your inquiry as quickly as possible.